Category: Becton Dickinson & Co.Syndicate content

BD-CareFusion deal passes US anti-trust waiting period

November 21, 2014 by Mark Hollmer

Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.

BD-CareFusion deal passes US anti-trust waiting period

BDX owes $340m to RVP in anti-trust case | Medtech legal news for the week of November 17, 2014

November 17, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: BD owes $340m to Retractable Technologies in anti-trust case; Feds indict Vascular Solutions, CEO over Vari-Lase; Federal jury begins deliberations in Boston Scientific mesh trial; Boston Scientific ordered to pay $26.7 million over mesh devices; Judge dismisses 76 Ethicon pelvic mesh lawsuits in Texas

BD owes $340m to Retractable Technologies in anti-trust case

November 11, 2014 by Brad Perriello

BD owes $340m to Retractable Technologies in anti-trust case

November 11, 2014 by Brad Perriello

A federal judge orders Becton, Dickinson & Co. to pay $340 million to Retractable Technologies for BD's claim that it had the 'world's sharpest needle.'

BD owes $340m to Retractable Technologies in anti-trust case

CareFusion's Q1 sales, earnings rise

November 7, 2014 by Brad Perriello

Sales and earnings rise during the fiscal 1st quarter for CareFusion as it prepares to be absorbed by Becton, Dickinson & Co.

CareFusion's Q1 sales, earnings rise

CareFusion (NYSE:CFN) ended its last fiscal quarter as a public company on a strong note, posting earnings growth of 2.8% on a top-line gain of 11.1%.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Becton Dickinson beats forecast with fiscal 2015 results

November 4, 2014 by MassDevice

Becton, Dickinson & Co. beats Wall Street's forecast with its fiscal 2015 sales and earnings, sending share prices up in pre-market training today.

Becton Dickinson beats forecast with fiscal 2015 results

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Becton Dickinson prevails in catheter patent case

October 23, 2014 by Val Kennedy

The U.S. Patent & Trademark Office's patent trial board rules in favor of Becton Dickinson in a case involving a catheter-assembly patent held by One StockDuq Holdings.

Becton Dickinson prevails in catheter patent case

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A

October 22, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp